CD274 and neoplasm: Both CD4+ T-cell lines did not respond to HLA-unmatched tumor cell lines (Fig. 3c), suggesting that our defined PD-L1241-265 peptide could efficiently stimulate PD-L1-expressing tumor-reactive HTLs.